Biostar Pharmaceuticals Inc
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common … Read more
Market Cap & Net Worth: Biostar Pharmaceuticals Inc (BSPM)
Biostar Pharmaceuticals Inc (PINK:BSPM) has a market capitalization of $263.72 ($263.72) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #49618 globally and #15172 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biostar Pharmaceuticals Inc's stock price $0.00 by its total outstanding shares 2637188 (2.64 Million).
Biostar Pharmaceuticals Inc Market Cap History: 2015 to 2025
Biostar Pharmaceuticals Inc's market capitalization history from 2015 to 2025. Data shows change from $7.41 Million to $263.72 (-68.32% CAGR).
Biostar Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biostar Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.24x
Biostar Pharmaceuticals Inc's market cap is 3.24 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $7.41 Million | $27.13 Million | -$25.11 Million | 0.27x | N/A |
| 2016 | $7.73 Million | $2.38 Million | -$5.70 Million | 3.24x | N/A |
Competitor Companies of BSPM by Market Capitalization
Companies near Biostar Pharmaceuticals Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Biostar Pharmaceuticals Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Biostar Pharmaceuticals Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Biostar Pharmaceuticals Inc's market cap moved from $7.41 Million to $ 263.72, with a yearly change of -68.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $263.72 | 0.00% |
| 2024 | $263.72 | 0.00% |
| 2023 | $263.72 | -99.00% |
| 2022 | $26.37K | +9900.00% |
| 2021 | $263.72 | -99.88% |
| 2020 | $210.98K | +33.33% |
| 2019 | $158.23K | -81.25% |
| 2018 | $843.90K | -81.92% |
| 2017 | $4.67 Million | -39.59% |
| 2016 | $7.73 Million | +4.34% |
| 2015 | $7.41 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Biostar Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $263.72 USD |
| MoneyControl | $263.72 USD |
| MarketWatch | $263.72 USD |
| marketcap.company | $263.72 USD |
| Reuters | $263.72 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.